These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11020292

  • 1. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
    Martín-Martínez M, De La Figuera N, Latorre M, Herranz R, García-López MT, Cenarruzabeitia E, Del Río J, González-Muñiz R.
    J Med Chem; 2000 Oct 05; 43(20):3770-7. PubMed ID: 11020292
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands.
    de la Figuera N, Martín-Martínez M, Herranz R, García-López MT, Latorre M, Cenarruzabeitia E, del Río J, González-Muñiz R.
    Bioorg Med Chem Lett; 1999 Jan 04; 9(1):43-8. PubMed ID: 9990454
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
    Higginbottom M, Hill DR, Horwell DC, Mostafai E, Suman-Chauhan N, Roberts E.
    Bioorg Med Chem; 1993 Sep 04; 1(3):209-17. PubMed ID: 8081854
    [Abstract] [Full Text] [Related]

  • 6. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM, Black JW, Broughton HB, Buck IM, Davies JM, Dunstone DJ, Hull RA, Kalindjian SB, McDonald IM, Pether MJ, Shankley NP, Steel KI.
    J Med Chem; 2000 Sep 21; 43(19):3505-17. PubMed ID: 11000005
    [Abstract] [Full Text] [Related]

  • 7. Development of CCK-B antagonists.
    Horwell DC.
    Neuropeptides; 1991 Jul 21; 19 Suppl():57-64. PubMed ID: 1881533
    [Abstract] [Full Text] [Related]

  • 8. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
    Bellier B, Da Nascimento S, Meudal H, Gincel E, Roques BP, Garbay C.
    Bioorg Med Chem Lett; 1998 Jun 02; 8(11):1419-24. PubMed ID: 9871777
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
    Bellier B, McCort-Tranchepain I, Ducos B, Danascimento S, Meudal H, Noble F, Garbay C, Roques BP.
    J Med Chem; 1997 Nov 21; 40(24):3947-56. PubMed ID: 9397175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. "Dipeptoids": from the chemical structure of the endogenous peptide to the design of peptidomimetics.
    Martín-Martínez M, Patiño-Molina R, García-López MT, González-Muñiz R.
    Mini Rev Med Chem; 2004 Aug 21; 4(6):669-80. PubMed ID: 15279601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR, Higginbottom M, Hill DR, Horwell DC, Hughes J, Rees DC, Roberts E, Singh L, Suman-Chauhan N, Woodruff GN.
    J Med Chem; 1993 Mar 05; 36(5):552-65. PubMed ID: 7684452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.